NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque-competence, Aβ(1-40)ox and Aβ(1-42)ox

被引:204
作者
Riek, R
Güntert, P
Döbeli, H
Wipf, B
Wüthrich, K [1 ]
机构
[1] ETH Honggerberg, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland
[2] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2001年 / 268卷 / 22期
关键词
Alzheimer's disease; aqueous solution; NMR; polypeptide; aggregation;
D O I
10.1046/j.0014-2956.2001.02537.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
NMR studies of amyloid beta -peptides (A beta) in aqueous solution provide a novel way in which to characterize the apparent Alzheimer's disease-related conformational polymorphism of A beta. In the aqueous medium, neither of the polypeptides A beta (1-40)(ox) or A beta (1-42)(ox) (both of which contain a methionine sulfoxide at position 35) is folded into a globular structure, but they both deviate from random coil behavior by local conformational preferences of several short segments along the amino-acid sequence. Differences between the solution structures of A beta (1-40)(ox) and A beta (1-42)(ox) are indicated only by decreased flexibility of the region from about residue 32 to the C-terminus in A beta (1-42)(ox) when compared to A beta (1-40)(ox). The lack of the observation of more extensive conformational differences between the two molecules is intriguing, considering that A beta (1-42)(ox) in aqueous solution has much higher plaque-competence than A beta (1-40)(ox).
引用
收藏
页码:5930 / 5936
页数:7
相关论文
共 44 条
[1]   THE PROGRAM XEASY FOR COMPUTER-SUPPORTED NMR SPECTRAL-ANALYSIS OF BIOLOGICAL MACROMOLECULES [J].
BARTELS, C ;
XIA, TH ;
BILLETER, M ;
GUNTERT, P ;
WUTHRICH, K .
JOURNAL OF BIOMOLECULAR NMR, 1995, 6 (01) :1-10
[2]   NATURAL ABUNDANCE N-15 NMR BY ENHANCED HETERONUCLEAR SPECTROSCOPY [J].
BODENHAUSEN, G ;
RUBEN, DJ .
CHEMICAL PHYSICS LETTERS, 1980, 69 (01) :185-189
[3]   Self-assembly of β-amyloid 42 is retarded by small molecular ligands at the stage of structural intermediates [J].
Bohrmann, B ;
Adrian, M ;
Dubochet, J ;
Kuner, P ;
Müller, F ;
Huber, W ;
Nordstedt, C ;
Döbeli, H .
JOURNAL OF STRUCTURAL BIOLOGY, 2000, 130 (2-3) :232-246
[4]  
BURDICK D, 1992, J BIOL CHEM, V267, P546
[5]   MUTATION OF THE BETA-AMYLOID PRECURSOR PROTEIN IN FAMILIAL ALZHEIMERS-DISEASE INCREASES BETA-PROTEIN PRODUCTION [J].
CITRON, M ;
OLTERSDORF, T ;
HAASS, C ;
MCCONLOGUE, L ;
HUNG, AY ;
SEUBERT, P ;
VIGOPELFREY, C ;
LIEBERBURG, I ;
SELKOE, DJ .
NATURE, 1992, 360 (6405) :672-674
[6]   Solution structure of amyloid β-peptide(1-40) in a water-micelle environment.: Is the membrane-spanning domain where we think it is? [J].
Coles, M ;
Bicknell, W ;
Watson, AA ;
Fairlie, DP ;
Craik, DJ .
BIOCHEMISTRY, 1998, 37 (31) :11064-11077
[7]  
CRESCENZI O, 2001, EUROESCO C NMR MOL B, P101
[8]   RELAXATION-RATE MEASUREMENTS FOR N-15-H-1 GROUPS WITH PULSED-FIELD GRADIENTS AND PRESERVATION OF COHERENCE PATHWAYS [J].
DAYIE, KT ;
WAGNER, G .
JOURNAL OF MAGNETIC RESONANCE SERIES A, 1994, 111 (01) :121-126
[9]   A BIOTECHNOLOGICAL METHOD PROVIDES ACCESS TO AGGREGATION COMPETENT MONOMERIC ALZHEIMERS 1-42 RESIDUE AMYLOID PEPTIDE [J].
DOBELI, H ;
DRAEGER, N ;
HUBER, G ;
JAKOB, P ;
SCHMIDT, D ;
SEILHEIMER, B ;
STUBER, D ;
WIPF, B ;
ZULAUF, M .
BIO-TECHNOLOGY, 1995, 13 (09) :988-993
[10]   Structure of the recombinant full-length hamster prion protein PrP(29-231): The N terminus is highly flexible [J].
Donne, DG ;
Viles, JH ;
Groth, D ;
Mehlhorn, I ;
James, TL ;
Cohen, FE ;
Prusiner, SB ;
Wright, PE ;
Dyson, HJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) :13452-13457